DV
Dividend Vision

CLDX — Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. (CLDX)

Its deepest 1-year drawdown was 24.2%.

CLDX is a single-stock equity holding in Celldex Therapeutics, a biopharmaceutical company, rather than a diversified ETF. The security does not currently pay dividends, resulting in no distribution rate or yield profile. This holding appeals primarily to investors seeking exposure to the biotech sector with a focus on capital appreciation rather than income generation.

CLDX key facts

Asset type
Stock
Asset class
Equity
Inception date
05/15/1986
Last close
$41.95
Market cap
$3,294,313,984
Average volume
849400.0
Payment date
02/11/2019
Beta
0.837
Payout ratio
0.0
Forward P/E
0.0
EPS
$-4.35